中国肝脏病杂志(电子版)
中國肝髒病雜誌(電子版)
중국간장병잡지(전자판)
CHINESE JOURNAL OF LIVER DISEASES(ELECTRONIC VERSION)
2014年
3期
35-38
,共4页
肝肿瘤%CT 灌注%可重复性
肝腫瘤%CT 灌註%可重複性
간종류%CT 관주%가중복성
Liver neoplasms%CT Perfusion%Reproducibility
目的:应用CT灌注成像前瞻性研究进展期肝细胞癌(HCC)的肿瘤血管,并评估CT灌注参数与肿瘤分级及肿瘤标记物的相关性。方法手术不能切除的HCC及肝转移患者30例(HCC组25例、肝转移组5例)静脉注射造影剂后,接受动态首次通过CT灌注扫描。收集数据计算CT灌注参数(肿瘤组织和肝组织的血流量、血容量、平均通过时间、表面通透性)。其中有4例患者在30小时内再行1次CT灌注扫描,以检验本研究的可重复性。CT灌注参数在不同级别的肿瘤、有无门静脉癌栓、肝硬化、无肝外转移患者中进行比较,并且评估CT灌注参数与AFP的相关性。应用单向方差分析来统计处理CT灌注参数在各个比较中的差异。结果本研究的可重复性检验良好(r =0.9,P <0.01)。在肝细胞肝癌组织与肝实质的CT灌注参数比较,差异有统计学意义(P <0.05)。高分化的HCC-CT灌注值高于低分化肿瘤(P <0.05)。有或无门静脉癌栓、有或无肝硬化患者的CT灌注值差异无统计学意义。淋巴结转移的CT灌注值低于其他肝外转移。CT灌注参数与AFP比较,差异无统计学意义(P >0.05)。结论 CT灌注成像是一项可行的、可重复性定量分析进展期肝癌肿瘤血供与肿瘤血管生成的检查手段。
目的:應用CT灌註成像前瞻性研究進展期肝細胞癌(HCC)的腫瘤血管,併評估CT灌註參數與腫瘤分級及腫瘤標記物的相關性。方法手術不能切除的HCC及肝轉移患者30例(HCC組25例、肝轉移組5例)靜脈註射造影劑後,接受動態首次通過CT灌註掃描。收集數據計算CT灌註參數(腫瘤組織和肝組織的血流量、血容量、平均通過時間、錶麵通透性)。其中有4例患者在30小時內再行1次CT灌註掃描,以檢驗本研究的可重複性。CT灌註參數在不同級彆的腫瘤、有無門靜脈癌栓、肝硬化、無肝外轉移患者中進行比較,併且評估CT灌註參數與AFP的相關性。應用單嚮方差分析來統計處理CT灌註參數在各箇比較中的差異。結果本研究的可重複性檢驗良好(r =0.9,P <0.01)。在肝細胞肝癌組織與肝實質的CT灌註參數比較,差異有統計學意義(P <0.05)。高分化的HCC-CT灌註值高于低分化腫瘤(P <0.05)。有或無門靜脈癌栓、有或無肝硬化患者的CT灌註值差異無統計學意義。淋巴結轉移的CT灌註值低于其他肝外轉移。CT灌註參數與AFP比較,差異無統計學意義(P >0.05)。結論 CT灌註成像是一項可行的、可重複性定量分析進展期肝癌腫瘤血供與腫瘤血管生成的檢查手段。
목적:응용CT관주성상전첨성연구진전기간세포암(HCC)적종류혈관,병평고CT관주삼수여종류분급급종류표기물적상관성。방법수술불능절제적HCC급간전이환자30례(HCC조25례、간전이조5례)정맥주사조영제후,접수동태수차통과CT관주소묘。수집수거계산CT관주삼수(종류조직화간조직적혈류량、혈용량、평균통과시간、표면통투성)。기중유4례환자재30소시내재행1차CT관주소묘,이검험본연구적가중복성。CT관주삼수재불동급별적종류、유무문정맥암전、간경화、무간외전이환자중진행비교,병차평고CT관주삼수여AFP적상관성。응용단향방차분석래통계처리CT관주삼수재각개비교중적차이。결과본연구적가중복성검험량호(r =0.9,P <0.01)。재간세포간암조직여간실질적CT관주삼수비교,차이유통계학의의(P <0.05)。고분화적HCC-CT관주치고우저분화종류(P <0.05)。유혹무문정맥암전、유혹무간경화환자적CT관주치차이무통계학의의。림파결전이적CT관주치저우기타간외전이。CT관주삼수여AFP비교,차이무통계학의의(P >0.05)。결론 CT관주성상시일항가행적、가중복성정량분석진전기간암종류혈공여종류혈관생성적검사수단。
Objective To prospectively assess computed tomographic (CT) perfusion for evaluation of tumor vascularity of advanced hepatocellular carcinoma (HCC) and to correlate CT perfusion parameters with tumor grade and serum markers. Methods Total of 30 patients with unresectable HCC and hepatic metastatic (25 cases of HCC, 5 cases of hepatic metastases) were accept dynamic by CT perfusion scan for the first time after intravenous contrast agent. CT perfusion parameters (tumor tissue, hepatic tissue blood flow, blood volume, mean transit time, permeability surface area product) were collected. Repeat examination was performed in four patients within 30 hours to test reproducibility of CT perfusion. CT perfusion parameters were compared among tumors of different grades, with presence or absence of portal vein invasion, with presence or absence of cirrhosis, and of various extrahepatic metastases. Parameters were correlated with HCC serum markers. One-way analysis of variance was used to calculate variations in CT perfusion parameters. Results Good correlation (r = 0.9, P < 0.01) was observed between repeat examination results and first CT examination results. There was a significant difference (P < 0.05) in CT perfusion parameters between primary HCC and background liver parenchyma. Well-differentiated HCC showed significantly higher perfusion values (P < 0.05) than other grades. There was no significant difference in tumor perfusion between presence or absence of portal vein invasion or cirrhosis. CT perfusion value of lymph node metastasis demonstrated was lower than that of other extrahepatic metastasis. There was no significant correlation between CT perfusion parameters and serum markers (P > 0.05). Conclusions CT perfusion is a feasible and, from the limited data, reproducible technique for quantifying tumor vascularity and angiogenesis in advanced HCC.